![Bart Schade](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Steven Mickelsen | M | - |
Field Medical, Inc.
![]() Field Medical, Inc. Medical SpecialtiesHealth Technology Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, CA. Field Medical is developing a proprietary technology called FieldBending™, which concentrates therapeutic effects and reduces unwanted far-field effects associated with first-generation PFA technology. The company aims to expand the indications for pulsed field ablation (PFA) beyond atrial fibrillation therapy by addressing more challenging arrhythmias in the ventricle and common procedures like supraventricular tachycardia (SVT) that require minimal sedation. The company was founded in 2022 by Steven Mickelsen, who has been the CEO since then. | 2 years |
Louise Janssen-Counotte | F | 59 |
Field Medical, Inc.
![]() Field Medical, Inc. Medical SpecialtiesHealth Technology Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, CA. Field Medical is developing a proprietary technology called FieldBending™, which concentrates therapeutic effects and reduces unwanted far-field effects associated with first-generation PFA technology. The company aims to expand the indications for pulsed field ablation (PFA) beyond atrial fibrillation therapy by addressing more challenging arrhythmias in the ventricle and common procedures like supraventricular tachycardia (SVT) that require minimal sedation. The company was founded in 2022 by Steven Mickelsen, who has been the CEO since then. | 1 years |
Mark Wisniewski | M | - |
Field Medical, Inc.
![]() Field Medical, Inc. Medical SpecialtiesHealth Technology Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, CA. Field Medical is developing a proprietary technology called FieldBending™, which concentrates therapeutic effects and reduces unwanted far-field effects associated with first-generation PFA technology. The company aims to expand the indications for pulsed field ablation (PFA) beyond atrial fibrillation therapy by addressing more challenging arrhythmias in the ventricle and common procedures like supraventricular tachycardia (SVT) that require minimal sedation. The company was founded in 2022 by Steven Mickelsen, who has been the CEO since then. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 3 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bart Schade
- Personal Network